triamterene has been researched along with Malignant Hypertension in 2 studies
Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| SINGER, MM | 1 |
| HOFF, HR | 1 |
| FISCH, S | 1 |
| DEGRAFF, AC | 1 |
| Hagino, K | 1 |
2 other studies available for triamterene and Malignant Hypertension
| Article | Year |
|---|---|
RED BLOOD CELL POTASSIUM; THERAPEUTIC IMPLICATIONS.
Topics: Anemia; Anemia, Hypochromic; Blood Platelets; Digitalis Glycosides; Diuretics; Erythrocytes; Fludroc | 1964 |
[Hypertension--malignant hypertension].
Topics: Diuretics; Hexamethonium Compounds; Humans; Hydrazines; Hypertension, Malignant; Male; Methyldopa; M | 1971 |